These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4453559)

  • 41. Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus.
    Watts NB; Spanheimer RG; DiGirolamo M; Gebhart SS; Musey VC; Siddiq YK; Phillips LS
    Arch Intern Med; 1990 Apr; 150(4):803-6. PubMed ID: 2327840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood glucose, serum immunoreactive insulin and growth hormone responses to intravenous infusion of an aminoacids mixture in healthy subjects and diabetics.
    Samal KC; Dash RJ; Sinha MK; Rastogi GK
    J Assoc Physicians India; 1977 Mar; 25(3):175-80. PubMed ID: 914746
    [No Abstract]   [Full Text] [Related]  

  • 43. The growth hormone dependent sulfation factor in serum from patients with various types of diabetes.
    Yde H
    Acta Med Scand; 1969 Oct; 186(4):293-7. PubMed ID: 5378107
    [No Abstract]   [Full Text] [Related]  

  • 44. Continuous blood glucose measurement and insulin levels in subjects with ideal body weight, normal body weight, non-diabetic overweight and obese subjects with impaired glucose tolerance.
    Dolderer M; De la Fuente A; Kerner W; Zier H; Pfeiffer EF
    Horm Metab Res Suppl; 1992; 26():24-7. PubMed ID: 1490688
    [No Abstract]   [Full Text] [Related]  

  • 45. [Influence of oral glucose load on the blood sugar and hormonal response during oral glucose tolerance tests over 5 hours in obese non-diabetic subjects].
    Eschwege E; Valleron AJ; Papoz L; Rosselin EG
    Ann Biol Clin (Paris); 1972; 30(3):225-32. PubMed ID: 5056533
    [No Abstract]   [Full Text] [Related]  

  • 46. [Somatotropic hormone, diabetes and diabetic angiopathy].
    Dobrev DG
    Vutr Boles; 1979; 18(5):21-7. PubMed ID: 390884
    [No Abstract]   [Full Text] [Related]  

  • 47. Response of immunoreactive growth hormone, immunoreactive insulin, free fatty acids and blood sugar to exercise in obese patients and in normal subjects.
    ter Haar DJ; van Riet HG; Thijssen JH; Schwarz F
    J Endocrinol; 1969 Jan; 43(1):xi-xii. PubMed ID: 5789228
    [No Abstract]   [Full Text] [Related]  

  • 48. Hormonal and metabolic studies of the action of fenfluramine in normal man, obesity, acromegaly and diabetes mellitus.
    Sulaiman WR; Johnson RH; Rennie MJ
    Postgrad Med J; 1975; 51 Suppl 1():125-31. PubMed ID: 1219669
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effect of adrenergic beta-blockade using trimepranol on glucose, insulin, somatotropin and nonesterified fatty acids in the blood of women with diabetes mellitus].
    Felt V; Nedvídkrová J; Hortová O
    Vnitr Lek; 1974 Nov; 20(11):1050-4. PubMed ID: 4155166
    [No Abstract]   [Full Text] [Related]  

  • 50. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma growth-hormone response to glucocorticoids in diabetics.
    Meek JC; Reitz RP; Bolinger RE
    Proc Soc Exp Biol Med; 1970 Oct; 135(1):123-6. PubMed ID: 5475608
    [No Abstract]   [Full Text] [Related]  

  • 52. Twenty-four-hour serum growth hormone levels in maturity-onset diabetics.
    Kjeldsen H; Hansen AP; Lundbaek K
    Diabetes; 1975 Nov; 24(11):977-82. PubMed ID: 1183733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Change in the lipid metabolism indices during the treatment of patients with diabetic obesity].
    Mikhailova EV
    Probl Endokrinol (Mosk); 1973; 19(3):8-11. PubMed ID: 4724068
    [No Abstract]   [Full Text] [Related]  

  • 54. Glucose tolerance, insulin, and growth hormone in thyrotoxicosis and in myxedema.
    Ohlsen PM; Danowski TS; Vidalon C; Ahmad U; Nolan S; Stephan T
    Endocr Res Commun; 1974; 1(5-6):435-48. PubMed ID: 4461267
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of biguanide derivatives (phenformin) on glucose tolerance in "borderline" and asymptomatic ("chemical") diabetes mellitus. Results of a 5-year prospective study].
    Kasperska-Czyzykowa T; Jaskólska K; Gałecki A; Trzaski M; Woy-Wojciechowski J
    Pol Arch Med Wewn; 1987 Nov; 78(5):241-50. PubMed ID: 3270805
    [No Abstract]   [Full Text] [Related]  

  • 56. Plasma growth hormone response to insulin-induced hypoglycemia in diabetes mellitus.
    Sinha MK; Malik GP; Rastogi GK
    Acta Diabetol Lat; 1974; 11(2):89-95. PubMed ID: 4432729
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of weight reduction on the glucose tolerance in obese maturity onset diabetics.
    Badran AM; Farid FF
    J Egypt Public Health Assoc; 1977; 52(6):425-31. PubMed ID: 617673
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of reducing diet on carbohydrate tolerance and therapeutic management of obese diabetics].
    Szybiński Z; Sieradzki J; Mruk K; Kucharski K; Poskuta W; Korzeniowska D; Jastrzebska E
    Pol Arch Med Wewn; 1978 Nov; 60(5):423-31. PubMed ID: 724544
    [No Abstract]   [Full Text] [Related]  

  • 59. [EXPERIENCES WITH THE THERAPEUTIC USE OF AN ANOREXIC SUBSTANCE ON DIABETES OF THE OBESE].
    MONTENERO P; COLLETTI A
    Minerva Med; 1964 Sep; 55():2800-5. PubMed ID: 14199468
    [No Abstract]   [Full Text] [Related]  

  • 60. Human growth hormone response to a fall in plasma glucose concentration in normal and diabetic subjects.
    Grecu EO; Walter RM
    Diabetologia; 1983 Feb; 24(2):136-7. PubMed ID: 6840422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.